From: Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Outcome | Characteristic | HR | 95% CI | P | |
---|---|---|---|---|---|
OS | PR | Negative | 1 | - | - |
 |  | Positive | 0.47 | 0.29-0.75 | < 0.01 |
 | Ki67 | Low | 1 | - | - |
 |  | High | 8.14 | 3.25-20.35 | < 0.0001 |
 | pCR | No | 1 | - | - |
 |  | Yes | 0.18 | 0.07-0.45 | < 0.001 |
DDFS | cT | 1 | 1 | - | - |
 |  | 2-4 | 2.42 | 0.88-6.59 | 0.08 |
 | PR | Negative | 1 | - | - |
 |  | Positive | 0.49 | 0.32-0.76 | < 0.01 |
 | Ki67 | Low | 1 | - | - |
 |  | High | 3.24 | 1.77-5.89 | < 0.001 |
 | pCR | No | 1 | - | - |
 |  | Yes | 0.16 | 0.07-0.43 | < 0.001 |
LRFS | PR | Negative | 1 | - | - |
 |  | Positive | 0.47 | 0.22-1.00 | 0.05 |
 | Ki67 | Low | 1 | - | - |
 |  | High | 1.81 | 0.75-4.36 | 0.18 |
 | pCR | No | 1 | - | - |
 |  | Yes | 0.83 | 0.34-2.02 | 0.69 |